Barclays
ACLX

Barclays’s Arcellx ACLX Stock Holding History

Barclays’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.8M Buy
207,642
+10,870
+6% +$959K 0.01% 1020
2025
Q4 		$12.8M Buy
196,772
+89,116
+83% +$7.11M ﹤0.01% 1506
2025
Q3 		$8.84M Sell
107,656
-31,722
-23% -$2.28M ﹤0.01% 1756
2025
Q2 		$9.18M Buy
139,378
+61,739
+80% +$3.84M ﹤0.01% 1649
2025
Q1 		$5.09M Sell
77,639
-13,956
-15% -$945K ﹤0.01% 1898
2024
Q4 		$7.02M Buy
91,595
+6,273
+7% +$542K ﹤0.01% 1859
2024
Q3 		$7.13M Buy
85,322
+47,852
+128% +$3.19M ﹤0.01% 1750
2024
Q2 		$2.07M Sell
37,470
-2,233
-6% -$121K ﹤0.01% 2118
2024
Q1 		$2.76M Sell
39,703
-89,723
-69% -$5.69M ﹤0.01% 2303
2023
Q4 		$7.18M Buy
129,426
+43,239
+50% +$1.95M ﹤0.01% 1791
2023
Q3 		$3.09M Buy
86,187
+10,591
+14% +$365K ﹤0.01% 1633
2023
Q2 		$2.39M Buy
75,596
+16,482
+28% +$630K ﹤0.01% 1772
2023
Q1 		$1.82M Sell
59,114
-10,208
-15% -$310K ﹤0.01% 2263
2022
Q4 		$2.15M Buy
69,322
+10,285
+17% +$236K ﹤0.01% 2218
2022
Q3 		$1.11M Buy
59,037
+58,544
+11,875% +$1.12M ﹤0.01% 2156
2022
Q2 		$9K Sell
493
-986
-67% -$12.7K ﹤0.01% 4659
2022
Q1 		$20K Buy
+1,479
New +$24.7K ﹤0.01% 4435

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Barclays's ACLX Position: Q1 2026 in Review

Barclays increased its Arcellx (ACLX) stake by 5.5% in Q1 2026, buying an estimated $959K and bringing the position to 207,642 shares worth $23.8M. The position accounts for 0.01% of the portfolio, ranked #1020.

Barclays first reported a position in ACLX in Q1 2022 and has held it in 17 quarters since. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Barclays held 207,642 shares of Arcellx worth $23.8M as of Q1 2026.
  • Barclays bought 10,870 Arcellx shares in Q1 2026, an estimated $959K.
  • Arcellx made up 0.01% of Barclays's portfolio in Q1 2026, its #1020 holding.
  • Barclays first reported a position in Arcellx in Q1 2022 and has held it in 17 quarters since.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.